Human Milk Oligosaccharides (HMO) Market

Chapter 1 Human Milk Oligosaccharides (HMO) Market Overview

1.1 Human Milk Oligosaccharides (HMO) Definition

1.2 Global Human Milk Oligosaccharides (HMO) Market Size Status and Outlook (2019-2032)

1.3 Global Human Milk Oligosaccharides (HMO) Market Size Comparison by Region (2019-2032)

1.4 Global Human Milk Oligosaccharides (HMO) Market Size Comparison by Type (2019-2032)

1.5 Global Human Milk Oligosaccharides (HMO) Market Size Comparison by Application (2019-2032)

1.6 Global Human Milk Oligosaccharides (HMO) Market Size Comparison by Sales Channel (2019-2032)

1.7 Human Milk Oligosaccharides (HMO) Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Human Milk Oligosaccharides (HMO) Market Snapshot

2.2 Global Human Milk Oligosaccharides (HMO) Market Volume & Revenue 2019-2025

2.3 Global Human Milk Oligosaccharides (HMO) Market Differential Growth Potential Analysis by Type, 2019-2032 (USD Million)

2.4 Global Human Milk Oligosaccharides (HMO) Market Differential Growth Potential Analysis by Application, 2019-2032 (USD Million)

2.5 Global Human Milk Oligosaccharides (HMO) Market Differential Growth Potential Analysis by Sales Channels, 2019-2032 (USD Million)

2.6 Global Human Milk Oligosaccharides (HMO) Market Differential Growth Potential Analysis by Region, 2019-2032 (USD Million)

Chapter 3 Human Milk Oligosaccharides (HMO) Market Segment Analysis by Player

3.1 Global Human Milk Oligosaccharides (HMO) Sales and Market Share by Player (2023-2025)

3.2 Global Human Milk Oligosaccharides (HMO) Revenue and Market Share by Player (2023-2025)

3.3 Global Human Milk Oligosaccharides (HMO) Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Human Milk Oligosaccharides (HMO) Market Segment Analysis by Type

4.1 Global Human Milk Oligosaccharides (HMO) Market by Type

4.1.1 2'-FL & 3-FL

4.1.2 Sialyllactose

4.1.3 LNT & LNnT

4.2 Global Human Milk Oligosaccharides (HMO) Sales and Market Share by Type (2019-2025)

4.3 Global Human Milk Oligosaccharides (HMO) Revenue and Market Share by Type (2019-2025)

4.4 Global Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2025)

4.5 Leading Players of Human Milk Oligosaccharides (HMO) by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Human Milk Oligosaccharides (HMO) Market Segment Analysis by Application

5.1 Global Human Milk Oligosaccharides (HMO) Market by Application

5.1.1 Infant Formula

5.1.2 Functional Food & Beverages

5.1.3 Food/Medical Supplements

5.1.4 Others

5.2 Global Human Milk Oligosaccharides (HMO) Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Human Milk Oligosaccharides (HMO) by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Human Milk Oligosaccharides (HMO) Market Segment Analysis by Sales Channel

6.1 Global Human Milk Oligosaccharides (HMO) Market by Sales Channel

6.1.1 Global Human Milk Oligosaccharides (HMO) Market, by Direct Channel Market Analysis 2019-2032 (USD Million)

6.1.2 Global Human Milk Oligosaccharides (HMO) Market, by Distribution Channel Market Analysis 2019-2032 (USD Million)

6.2 Global Human Milk Oligosaccharides (HMO) Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Human Milk Oligosaccharides (HMO) by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Human Milk Oligosaccharides (HMO) Market Segment Analysis by Region

7.1 Global Human Milk Oligosaccharides (HMO) Market Size and CAGR by Region (2019-2032)

7.2 Global Human Milk Oligosaccharides (HMO) Sales and Market Share by Region (2019-2025)

7.3 Global Human Milk Oligosaccharides (HMO) Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Human Milk Oligosaccharides (HMO) Market Share by Type

7.4.3 North America Human Milk Oligosaccharides (HMO) Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Human Milk Oligosaccharides (HMO) Market Share by Type

7.5.3 Europe Human Milk Oligosaccharides (HMO) Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share by Type

7.6.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Human Milk Oligosaccharides (HMO) Market Share by Type

7.7.3 South America Human Milk Oligosaccharides (HMO) Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share by Type

7.8.3 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.8.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Human Milk Oligosaccharides (HMO) Players

8.1 Abbott

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Inbiose

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Glycom

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Chr. Hansen (Jennewein)

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 ZuChem

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Glycom

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Others

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Human Milk Oligosaccharides (HMO)

9.1 Industrial Chain of Human Milk Oligosaccharides (HMO)

9.2 Upstream of Human Milk Oligosaccharides (HMO)

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Human Milk Oligosaccharides (HMO)

9.3.1 Leading Distributors/Dealers of Human Milk Oligosaccharides (HMO)

9.3.2 Leading Consumers of Human Milk Oligosaccharides (HMO)

Chapter 10. Global Human Milk Oligosaccharides (HMO) Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Human Milk Oligosaccharides (HMO) Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Human Milk Oligosaccharides (HMO) Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Human Milk Oligosaccharides (HMO) (2026-2032)

11.1 Global Human Milk Oligosaccharides (HMO) Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Human Milk Oligosaccharides (HMO) Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Human Milk Oligosaccharides (HMO) Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Human Milk Oligosaccharides (HMO) Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Human Milk Oligosaccharides (HMO) Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Human Milk Oligosaccharides (HMO) Import-Export, 2019-2025

12.2 Europe Human Milk Oligosaccharides (HMO) Import-Export, 2019-2025

12.3 Asia Pacific Human Milk Oligosaccharides (HMO) Import-Export, 2019-2025

12.4 South America Human Milk Oligosaccharides (HMO) Import-Export, 2019-2025

12.5 Middle East & Africa Human Milk Oligosaccharides (HMO) Import-Export, 2019-2025

Chapter 13. Demand-Supply Gap Analysis (If Applicable)

13.1 North America Human Milk Oligosaccharides (HMO) Demand-Supply, 2019-2025

13.2 Europe Human Milk Oligosaccharides (HMO) Demand-Supply, 2019-2025

13.3 Asia Pacific Human Milk Oligosaccharides (HMO) Demand-Supply, 2019-2025

13.4 South America Human Milk Oligosaccharides (HMO) Demand-Supply, 2019-2025

13.5 Middle East & Africa Human Milk Oligosaccharides (HMO) Demand-Supply, 2019-2025

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources